Terms: = Brain cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Prognosis
30 results:
1. Nervous system (NS) Tumors in cancer Predisposition Syndromes.
Patil P; Pencheva BB; Patil VM; Fangusaro J
Neurotherapeutics; 2022 Oct; 19(6):1752-1771. PubMed ID: 36056180
[TBL] [Abstract] [Full Text] [Related]
2. The prognostic role of the immunohistochemical expression of S100 in meningiomas.
Behling F; Fodi C; Skardelly M; Paulsen F; Tabatabai G; Honegger J; Tatagiba M; Schittenhelm J
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2975-2985. PubMed ID: 35838837
[TBL] [Abstract] [Full Text] [Related]
3. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C
Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic impact of genetic alterations and methylation classes in meningioma.
Berghoff AS; Hielscher T; Ricken G; Furtner J; Schrimpf D; Widhalm G; Rajky U; Marosi C; Hainfellner JA; von Deimling A; Sahm F; Preusser M
Brain Pathol; 2022 Mar; 32(2):e12970. PubMed ID: 35213082
[TBL] [Abstract] [Full Text] [Related]
5. Intracranial metastasis from a malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1: A case study and literature review.
Griffin S; Witt MC; El Tecle N; Prim M; Hockman J; Schwetye KE; Pierson MJ
Clin Neurol Neurosurg; 2021 Apr; 203():106540. PubMed ID: 33607580
[TBL] [Abstract] [Full Text] [Related]
6. Associations of meningioma molecular subgroup and tumor recurrence.
Youngblood MW; Miyagishima DF; Jin L; Gupte T; Li C; Duran D; Montejo JD; Zhao A; Sheth A; Tyrtova E; Özduman K; Iacoangeli F; Peyre M; Boetto J; Pease M; Avşar T; Huttner A; Bilguvar K; Kilic T; Pamir MN; Amankulor N; Kalamarides M; Erson-Omay EZ; Günel M; Moliterno J
Neuro Oncol; 2021 May; 23(5):783-794. PubMed ID: 33068421
[TBL] [Abstract] [Full Text] [Related]
7. Genetic alterations in non-syndromic, familial gliomas in first degree relatives: A systematic review.
Vasilica AM; Sefcikova V; Samandouras G
Clin Neurol Neurosurg; 2020 Nov; 198():106222. PubMed ID: 33039851
[TBL] [Abstract] [Full Text] [Related]
8. The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies.
Prager BC; Vasudevan HN; Dixit D; Bernatchez JA; Wu Q; Wallace LC; Bhargava S; Lee D; King BH; Morton AR; Gimple RC; Pekmezci M; Zhu Z; Siqueira-Neto JL; Wang X; Xie Q; Chen C; Barnett GH; Vogelbaum MA; Mack SC; Chavez L; Perry A; Raleigh DR; Rich JN
Cancer Discov; 2020 Nov; 10(11):1722-1741. PubMed ID: 32703768
[TBL] [Abstract] [Full Text] [Related]
9. Pediatric clear cell meningioma involving the middle cranial fossa in the context of nf2 and SMARCE1 mutations.
Libert DM; Prayson RA
Ann Diagn Pathol; 2020 Jun; 46():151516. PubMed ID: 32311644
[TBL] [Abstract] [Full Text] [Related]
10. Cell-free circulating tumor DNA in patients with high-grade glioma as diagnostic biomarker - A guide to future directive.
Ahmed KI; Govardhan HB; Roy M; Naveen T; Siddanna P; Sridhar P; Suma MN; Nelson N
Indian J Cancer; 2019; 56(1):65-69. PubMed ID: 30950448
[TBL] [Abstract] [Full Text] [Related]
11. Six cases of sporadic schwannomatosis: Topographic distribution and outcomes of peripheral nerve tumors.
Chick G; Victor J; Hollevoet N
Hand Surg Rehabil; 2017 Oct; 36(5):378-383. PubMed ID: 28781128
[TBL] [Abstract] [Full Text] [Related]
12. Genetic differences on intracranial versus spinal cord ependymal tumors: a meta-analysis of genetic researches.
Lee CH; Chung CK; Kim CH
Eur Spine J; 2016 Dec; 25(12):3942-3951. PubMed ID: 27637901
[TBL] [Abstract] [Full Text] [Related]
13. [Multiple meningiomas].
Terrier LM; François P
Neurochirurgie; 2016 Jun; 62(3):128-35. PubMed ID: 27234913
[TBL] [Abstract] [Full Text] [Related]
14. Neurofibromatosis type 2.
Evans DG
Handb Clin Neurol; 2015; 132():87-96. PubMed ID: 26564072
[TBL] [Abstract] [Full Text] [Related]
15. Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2.
Stivaros SM; Stemmer-Rachamimov AO; Alston R; Plotkin SR; Nadol JB; Quesnel A; O'Malley J; Whitfield GA; McCabe MG; Freeman SR; Lloyd SK; Wright NB; Kilday JP; Kamaly-Asl ID; Mills SJ; Rutherford SA; King AT; Evans DG
J Med Genet; 2015 Aug; 52(8):557-62. PubMed ID: 26104281
[TBL] [Abstract] [Full Text] [Related]
16. Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (nf2) and meningioma 1 (MN1) genes.
Zhang X; Jia H; Lu Y; Dong C; Hou J; Wang Z; Wang F; Zhong H; Wang L; Wang K
Discov Med; 2014 Dec; 18(101):301-311. PubMed ID: 25549701
[TBL] [Abstract] [Full Text] [Related]
17. Oncogenic role of merlin/nf2 in glioblastoma.
Guerrero PA; Yin W; Camacho L; Marchetti D
Oncogene; 2015 May; 34(20):2621-30. PubMed ID: 25043298
[TBL] [Abstract] [Full Text] [Related]
18. Spinal intradural malignant peripheral nerve sheath tumor in a child with neurofibromatosis type 2: the first reported case and literature review.
Wu L; Deng X; Yang C; Xu Y
Turk Neurosurg; 2014; 24(1):135-9. PubMed ID: 24535811
[TBL] [Abstract] [Full Text] [Related]
19. Characterization of early onset neurofibromatosis type 2.
Matsuo M; Ohno K; Ohtsuka F
Brain Dev; 2014 Feb; 36(2):148-52. PubMed ID: 23414620
[TBL] [Abstract] [Full Text] [Related]
20. Identification of novel small-molecule inhibitors of glioblastoma cell growth and invasion by high-throughput screening.
Wang L; Zhao H; Cui K; Yao L; Ren M; Hao A; Smollen P; Nie F; Jin G; Liu Q; Wong ST
Biosci Trends; 2012 Aug; 6(4):192-200. PubMed ID: 23006966
[TBL] [Abstract] [Full Text] [Related]
[Next]
